Genomics Collaborative is Drug Discovery in United States that focus on Global Repository business. Founded in 1998. They cover business area such as developer, an integrate discovery platform, genomic and proteomic discovery, clinical sample, method, application, human genetic, validation, drug discovery, GCI platform, GCI Discovery, Global Repository, improvement, diagnosis, prediction, prevention, treatment, disease.
1998
( 26 years old in 2024 )
Global Repository
-
99 Erie Street
Cambridge, MA 02139
United States
Private
developeran integrate discovery platformgenomic and proteomic discoveryclinical samplemethodapplicationhuman geneticvalidationdrug discoveryGCI platformGCI DiscoveryGlobal Repositoryimprovementdiagnosispredictionpreventiontreatmentdisease
* We use standard office opening hours in near Genomics Collaborative's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Genomics Collaborative is Drug Discovery business from United States that founded in 1998 (26 years old in 2024), Genomics Collaborative business is focusing on Global Repository.
Genomics Collaborative headquarter office and corporate office address is located in 99 Erie Street Cambridge, MA 02139 United States.
Genomics Collaborative was founded in United States.
In 2024, Genomics Collaborative is currently focus on Global Repository sector.
Above is snippet of Google Trends for "Global Repository" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Genomics Collaborative, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
